Pfizer (PFE - Get Report) has dominated headlines this year with its failed Allergan (AGN - Get Report) merger and its Anacor Pharmaceuticals (ANAC) purchase. Nevertheless, Tom Forester, portfolio manager for the Forester Value Fund (FVALX - Get Report) , said there is more to the drug giant's stock higher than deal-making. 'Pfizer is not all about acquisitions, it has a great pipeline,' said Forester. 'And it has easier comps on the horizon because it has been over a year since a number of its previous blockbuster drugs came off patent.' Last week Pfizer, up 6.3 percent thus far in 2016, announced its plan to spend $5.2 billion on Anacor Pharmaceuticals to build up its inflammation and immunology business. The deal gives Pfizer access to Crisaborole, an anti-inflammatory drug currently under U.S. Food and Drug Administration review for the treatment of mild-to-moderate atopic dermatitis, or eczema. The Forester Value Fund is down 60 basis points thus far in 2016, according to Morningstar. The $98 million fund has returned an average of 2% annually over the past decade, putting it in the 91% percentile in Morningstar's long/short equity category.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Video
Why Amazon Could Be a Tailwind for Kohl's, TJX -- ICYMI
Plus, see what Home Depot and Kohl's both told us about the state of retail and the consumer right now.
Striking Options: Gold, U.S. Dollar and a Market Bounce
Gold tests the lower end of its yearly range.
From McDonald's to Starbucks: The Biggest Fast-Food Chains In the World
McDonald's and Starbucks are two of the biggest fast-food chains in the world. Here's a breakdown of the biggest fast-food chains in the world.